Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. (2012)

First Author: Boumans MJ
Attributed to:  Centre for Musculoskeletal Ageing Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2011-200198

PubMed Identifier: 22072013

Publication URI: http://europepmc.org/abstract/MED/22072013

Type: Journal Article/Review

Volume: 71

Parent Publication: Annals of the rheumatic diseases

Issue: 1

ISSN: 0003-4967